Search Results - "Hørding, U"

Refine Results
  1. 1

    Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies by Hørding, U, Junge, J, Daugaard, S, Lundvall, F, Poulsen, H, Bock, J E

    Published in Gynecologic oncology (01-02-1994)
    “…The vulvectomy specimens of 78 patients with vulvar squamous cell carcinoma were reviewed and examined for human papillomavirus (HPV) types 6, 11, 16, 18, and…”
    Get more information
    Journal Article
  2. 2

    Vulvar Intraepithelial Neoplasia III: A Viral Disease of Undetermined Progressive Potential by Hørding, Ulla, Junge, Jette, Poulsen, Hemming, Lundvall, Finn

    Published in Gynecologic oncology (01-02-1995)
    “…Seventy-three patients with vulvar intraepithelial neoplasia (VIN) grade III were followed for a median of 5 years after primary treatment. Thirty women also…”
    Get full text
    Journal Article
  3. 3

    Human papillomavirus in vulvar squamous-cell carcinoma and in normal vulvar tissues: a search for a possible impact of HPV on vulvar cancer prognosis by Hørding, U, Kringsholm, B, Andreasson, B, Visfeldt, J, Daugaard, S, Bock, J E

    Published in International journal of cancer (30-09-1993)
    “…Paraffin-embedded sections of vulvar squamous-cell carcinomas and of normal vulvar tissues were examined for HPV types 6, 11, 16, 18 and 33 by the polymerase…”
    Get more information
    Journal Article
  4. 4

    Human papillomavirus (HPV) in vulvar dysplasia and carcinoma in situ by Junge, J, Poulsen, H, Horn, T, Hørding, U, Lundvall, F

    “…Surgical specimens from 62 patients with vulvar dysplasia and carcinoma in situ were morphologically investigated. Lesions were classified according to WHO…”
    Get more information
    Journal Article
  5. 5

    Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study by Lauritzen, A F, Hørding, U, Nielsen, H W

    “…During recent years numerous studies have demonstrated the presence of Epstein-Barr virus (EBV) in tissues affected by Hodgkin's disease (HD). The percentage…”
    Get more information
    Journal Article
  6. 6

    The pituitary-gonadal axis in women with benign or malignant ovarian tumors by Blaakaer, J, Djursing, H, Hørding, U, Bennett, P, Toftager-Larsen, K, Bock, J E, Lebech, P E

    Published in Acta endocrinologica (Copenhagen) (01-08-1992)
    “…The serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), human chorionic gonadotropin (hCG), estradiol, progesterone, androstenedione,…”
    Get more information
    Journal Article
  7. 7

    Plasma tetranectin and ovarian neoplasms by Høgdall, C K, Høgdall, E V, Hørding, U, Daugaard, S, Clemmensen, I, Nørgaard-Pedersen, B, Toftager-Larsen, K

    Published in Gynecologic oncology (01-11-1991)
    “…Plasma tetranectin was measured in 67 controls, 121 patients with a benign or malignant ovarian tumor, and 24 patients with another benign gynecologic disease…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Stage I endometrial carcinoma: a review of 140 patients primarily treated by surgery only by Hørding, U, Hansen, U

    Published in Gynecologic oncology (01-09-1985)
    “…One hundred patients with stage Ia and 40 patients with stage Ib endometrial carcinoma had hysterectomy and bilateral salpingo-oophorectomy performed as the…”
    Get more information
    Journal Article
  10. 10

    Human papillomavirus and Epstein-Barr virus in the etiology of testicular germ cell tumours by Rajpert-De Meyts, E, Hørding, U, Nielsen, H W, Skakkebaek, N E

    “…Epidemiological features suggest that the risk of testicular cancer may be related to exposure to unknown infectious agents, including viruses. Therefore a…”
    Get more information
    Journal Article
  11. 11

    Pre-operative plasma tetranectin as a prognostic marker in ovarian cancer patients by Høgdall, C K, Høgdall, E V, Hørding, U, Clemmensen, I, Nørgaard-Pedersen, B, Toftager-Larsen, K

    “…Plasma tetranectin (TN) was tested as a biochemical prognostic marker in ovarian cancer on 39 patients. In stage I + II the 5-year survival was 33% (2/6) if…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Serum tetranectin and CA-125 used to monitor the course of treatment in ovarian cancer patients by Høgdall, C K, Hørding, U, Nørgaard-Pedersen, B, Toftager-Larsen, K, Clemmensen, I

    “…Serum tetranectin (Se-TN) and CA-125 were measured in serum samples obtained before primary surgery, before start of chemotherapy and monthly during…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Cervical koilocytosis and high risk HPV types: the benefit of laser vaporization by Hørding, U, Rygaard, C, Ruge, S, Felding, C, Lundvall, F, Junge, J

    “…Forty-six patients with biopsy-proven cervical koilocytosis, which in 19 cases was associated with CIN I, were randomized to treatment by cervical laser…”
    Get more information
    Journal Article
  18. 18

    Hormonal factors and prognosis in epithelial ovarian cancer: a multivariate analysis by Blaakaer, J, Høgdall, C K, Hørding, U, Bennett, P, Toftager-Larsen, K, Daugaard, S, Bock, J

    “…When a significantly lower follicle stimulating hormone (FSH) level was found in patients with epithelial ovarian carcinoma, it was decided to analyze the…”
    Get more information
    Journal Article
  19. 19

    Cytokeratin intermediate filament pattern in uterine cervical biopsies by Nielsen, L N, Hørding, U, Daugaard, S, Rasmussen, L P, Johannesen, C L, Norrild, B

    “…Twenty-seven uterine cervical biopsies with histological diagnoses ranging from normal through dysplasia to invasive carcinoma were analysed for cytokeratin…”
    Get more information
    Journal Article
  20. 20

    Prevalence of human papillomavirus types 11, 16 and 18 in cervical swabs. A study of 1362 pregnant women by Hørding, U, Iversen, A K, Sebbelov, A, Bock, J E, Norrild, B

    “…Cervical smears from 1362 pregnant women were examined by filter in situ hybridisation for human papillomavirus (HPV) types 11, 16 and 18. 119 women (8.7%) had…”
    Get more information
    Journal Article